Human Genetics Flashcards
376-388 & 251, 253/4, 389 (34 cards)
f
Identify the two major classes of normal genes that can mutate and lead to cancer. Describe their normal functions.
The two major classes of normal genes that can lead to cancer after undergoing mutations are 1) the tumour suppressor genes that normally repress cell division, and 2) the proto-oncogenes, the normal function of which is to promote cell division.
Name three mechanisms by which proto-oncogenes can be converted into oncogenes.
Three mechanisms by which proto-oncogenes can be converted into oncogenes are point mutations, translocations, and over-expression. The latter includes amplification and the acquisition of a new promoter or enhancer.
What is the Philadelphia chromosome?
forms when chromosome 9 and chromosome 22 break and exchange parts. This creates a short chromosome 22 and a new combination of instructions for the cells. These new instructions can lead to the development of chronic myelogenous leukemia.
What are the two fundamental properties shared by cancer cells?
- proliferation: abnormal gell growth and division
- metastasis: defects in the normal restraints that keep cells from spreading and colonizing other parts of the body
What is a benign tumor?
a multicellular mass caused by a cell losing its genetic control over cell growth
* can be removed by surgery and cause no serious harm
What is a malignant tumor?
when cells in the tumor have the ability to break loose, enter the bloodstream, invade other tumors and form secondary tumors (metases)
* difficult to treat and often life-threatening
Do cancers arise from single mutations or multiple mutations?
cancers arise from the accumulation of many mutations in many genes
* mutations that lead to cancer affect multiple cellular functions, including repair of DNA damage, cell division, apoptosis, cellular differentiation, migratory behavior, and cell-cell contact
what does “the clonal origin of cancer cells” mean?
all cancer cells in primary and secondary tumors are clonal, meaning that they originated from a common ancestral cell that accumulated specific cancer-causing mutations
What kinds of cancers are characteristically related to reciprocal chromosomal translocations?
- leukemias
- lymphomas
- (hint: both involve white blood cells)
What are driver and passenger mutations?
- driver mutations: mutations that give growth advantage to a tumor cell (onlt a handful in each tumor, between 2-8)
- passenger mutations: the remainder of mutations acqured over time that have no direct contribution to the cancer phenotype
What is the cancer stem cell hypothesis?
most of the cells within tumors do not proliferate
* those that do not proliferate are known as cancer stem cells
* contrasts models that predict that every cell within a tumor has the potential to form a new tumor
What is the rate of mutations in humans?
10^-6 mutations per gene, per cell division, mainly due to the intrinsic eror rates of DNA replication
What is the rate of cancer in humans?
1/3
What are carcinogens and how do they contribute to the hypothesis of cancer being a multistep process?
cancer-causing agents
* exposure to carcinogens and appearance of cancer is delayed by an incubation period
What is tumorigenesis?
the development of a malignant tumor
What are the steps of developing colorectal cancers?
- conversion of normal epithelial cell into small cluster of cells called a polyp (or adenoma). this requires inactivating mutations in APC gene.
- acquisition of second genetic alteration in one of the cells within the small polyp. usually mutation in KRAS gene.
- transforms the a large polyp into a malignant tumor (carcinoma) is caused by defects in several genes
What is the mutator phenotype?
the high level of genomic instability seen in cancer cells - less ability to repair DNA damage and increases susceptibility to cancer-causing driver mutations
What is epigenetics?
the study of chromosome-associated changes that affect gene expression but do not alter the nucleotide sequence of DNA
At what stage of the cell cycle do cancer cells bypass?
cancer cells cannot enter the G0 (stop) phase of the cell cycle where cells do not divide but remain metabolically active.
* cancer cells are unable to enter G0
* they continuously cycle
* the rate of proliferation is not greater than a normal cell, they just do not stop at the proper time or place
what is signal transduction and how does it relate to cancer cells?
signal transduction is the process of transmitting growth signals from the external environment to the cell nucleus (tell the cell to reenter the cell cycle because there is a need for it e.g. healing)
* in cancer cells, there are often defects in the signal transduction pathways
* sometimes abnormal signal transfuction molecules send continuous growth signals to the nucleus (when not needed)
Should you perform presymptomatic testing for Huntington’s disease on your children to determine if they have inherited the disorder?
It is very clear that minors should never be tested presymptomatically, and that the decision to be tested must be the sole choice of the person concerned. Requests from third parties, be they family members or otherwise should never be considered.
You are a genetic counsellor and Winnie (27) comes to your clinic regarding her late father’s Huntington diagnosis, wanting to know if she has inherited it. She also wants to marry a man named Peter and wants to know if he will be a carrier. What information will you provide her with?
- verify that the father’s diagnosis is right and not just an assumption.
- make sure that information regarding the disease, its course and development, its inheritance and risk of occurrence in the present and next generations is well understood.
- discuss the availability, possibility, and implications of testing, and to encourage Winnifred to choose a companion (friend, relative, or Peter, depending on the relationship) to accompany her throughout the various stages before, during, and after the test if she decides to go through with it.
- address, if necessary, the distinction between marriage and parenthood and discuss, if appropriate, other forms of parenting like adoption or ovum transfer.
- provide, if not already known, further information about research and DNA banking options for affected and older unaffected individuals, their spouses, and seriously affected family members who have not been tested.
Give some real-world examples of genetic screening and testing.
- PKU screening in newborn babies
- Sickle-cell anemia carrier testing (autosomal recessive disease) in Africa
- Cytogenetic examination of amniotic fluid (amniocentesis) of older women to test for Down Syndrome
- Maternal Serum Screening Program (neural tube defects, trisomy 18, trisomy 21)
Mrs. van der Westhuyzen is only 22 years old and knows women over 35 have an increased probability of having children with Down syndrome. She therefore decides not to have a maternal serum screen done. Is she right?
A decision to undergo maternal serum screening should not be based on age alone. The question Mrs. van der Westhuyzen should ask herself is whether she wants to know if she has a higher probability of having a child with Down syndrome or a neural tube defect. If she does not want to know, she should not undergo screening. If she wants to know, the best way to find out is to undergo serum screening with due consideration given to biochemical findings, her own age, her gestational age, her weight, diabetic status, etc. Any decision based on only one, rather than all these criteria, does not seem to be wise.